Trial Profile
A phase 3, multicenter, randomized, double-blind, comparative study of the efficacy and safety of tigecycline vs levofloxacin to treat subjects hospitalized with community-acquired pneumonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2013
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Levofloxacin
- Indications Community-acquired pneumonia; Pneumococcal infections
- Focus Registrational; Therapeutic Use
- 21 Oct 2008 Results published.
- 18 Oct 2006 Status change
- 27 Sep 2005 New trial record.